SI3038654T1 - Nova uporaba - Google Patents

Nova uporaba

Info

Publication number
SI3038654T1
SI3038654T1 SI201431464T SI201431464T SI3038654T1 SI 3038654 T1 SI3038654 T1 SI 3038654T1 SI 201431464 T SI201431464 T SI 201431464T SI 201431464 T SI201431464 T SI 201431464T SI 3038654 T1 SI3038654 T1 SI 3038654T1
Authority
SI
Slovenia
Prior art keywords
new use
new
Prior art date
Application number
SI201431464T
Other languages
English (en)
Inventor
Victor Chengwei Shi
Martin Lefkowitz
Adel Remond Rizkala
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51494327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3038654(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2013/056680 external-priority patent/WO2015030711A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SI3038654T1 publication Critical patent/SI3038654T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
SI201431464T 2013-08-26 2014-08-26 Nova uporaba SI3038654T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US2013/056680 WO2015030711A1 (en) 2013-08-26 2013-08-26 New use
US201461972933P 2014-03-31 2014-03-31
EP14761702.1A EP3038654B1 (en) 2013-08-26 2014-08-26 New use
PCT/IB2014/064074 WO2015028941A1 (en) 2013-08-26 2014-08-26 New use

Publications (1)

Publication Number Publication Date
SI3038654T1 true SI3038654T1 (sl) 2020-02-28

Family

ID=51494327

Family Applications (2)

Application Number Title Priority Date Filing Date
SI201431464T SI3038654T1 (sl) 2013-08-26 2014-08-26 Nova uporaba
SI201432059T SI3626270T1 (sl) 2013-08-26 2014-08-26 Zdravljenje srčno-žilnih bolezni

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI201432059T SI3626270T1 (sl) 2013-08-26 2014-08-26 Zdravljenje srčno-žilnih bolezni

Country Status (15)

Country Link
US (2) US20160213646A1 (sl)
EP (3) EP3626270B1 (sl)
JP (1) JP6097888B2 (sl)
CY (1) CY1122531T1 (sl)
DK (2) DK3626270T3 (sl)
ES (1) ES2767084T3 (sl)
FI (1) FI3626270T3 (sl)
HR (2) HRP20240034T1 (sl)
HU (2) HUE064634T2 (sl)
LT (2) LT3038654T (sl)
PL (2) PL3626270T3 (sl)
PT (2) PT3626270T (sl)
RS (2) RS65037B1 (sl)
SI (2) SI3038654T1 (sl)
WO (1) WO2015028941A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3253740A1 (en) * 2015-02-06 2017-12-13 Mylan Laboratories Ltd. Amorphous trisodium sacubitril valsartan and a process for the preparation thereof
EP3302460A1 (en) * 2015-05-29 2018-04-11 Novartis AG Sacubitril and valsartan for treating metabolic disease
CN106309388A (zh) * 2015-06-30 2017-01-11 深圳信立泰药业股份有限公司 一种用于心衰治疗的药物组合物及其制备方法
CN106491600A (zh) * 2015-09-06 2017-03-15 常州方楠医药技术有限公司 无定型沙库区比、缬沙坦或其药学上可接受的盐与药用辅料的组合物及其制备方法
WO2017036420A1 (zh) * 2015-09-06 2017-03-09 常州方楠医药技术有限公司 含沙库比曲和缬沙坦的药用组合物及其制备方法
CN107510653A (zh) * 2016-06-17 2017-12-26 常州爱诺新睿医药技术有限公司 一种含有无定型沙库比曲和缬沙坦的固体分散体的药用组合物及其制备方法
WO2017042700A1 (en) * 2015-09-07 2017-03-16 Sun Pharmaceutical Industries Limited Solid forms of valsartan and sacubitril
US20180303799A1 (en) * 2015-10-16 2018-10-25 Shenzhen Salubris Pharmaceuticals Co., Ltd An Oral Preparation for the Treatment of Cardiovascular Disease and Its Preparation Method
CN105330609B (zh) * 2015-12-07 2017-12-22 南京正大天晴制药有限公司 一种制备lcz696的方法
JP7156945B2 (ja) 2016-02-03 2022-10-19 ノバルティス アーゲー 有機化合物のガレヌス製剤
CN106176681A (zh) * 2016-08-25 2016-12-07 泰力特医药（湖北）有限公司 一种抗心脏衰竭药物lcz696口服缓释微丸及其制备方法
WO2019008485A1 (en) 2017-07-06 2019-01-10 Mankind Pharma Ltd FIXED DOSE PHARMACEUTICAL COMPOSITION BASED ON VALSARTAN AND SACUBITRIL
KR20210032437A (ko) * 2018-08-23 2021-03-24 노파르티스 아게 심부전의 치료를 위한 신규한 약제학적 용도
WO2020039394A1 (en) 2018-08-24 2020-02-27 Novartis Ag New drug combinations
CA3151788A1 (en) * 2019-09-20 2021-03-25 Jingchao Sun Uses of complex of angiotensin ii receptor antagonist metabolite and nep inhibitor in treating heart failure

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000050I1 (de) 1990-02-19 2007-11-08 Novartis Ag Acylverbindungen
US5217996A (en) 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
WO1998030216A1 (en) * 1997-01-10 1998-07-16 Merck & Co., Inc. Use of angiotensin ii antagonists to treat symptomatic heart failure
CA2472399C (en) 2002-01-17 2012-02-21 Novartis Ag Pharmaceutical compositions comprising valsartan and nep inhibitors
EP1631556A1 (en) * 2003-05-16 2006-03-08 Novartis AG Pharmaceutical composition comprising valsartan
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
SI2217205T1 (sl) 2007-11-06 2015-10-30 Novartis Ag Farmacevtske sestave na podlagi superstruktur zaviralca/blokatorja angiotenzinskih receptorjev (arb) in inhibitorja nevtralne endopeptidaze (nep)
JP6041489B2 (ja) 2008-11-22 2016-12-07 ジェネンテック， インコーポレイテッド 乳癌の治療のための化学療法と併用した抗ｖｅｇｆ抗体の使用
AU2011293648B2 (en) * 2010-08-24 2015-02-12 Novartis Ag Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy
MX2015002432A (es) * 2012-08-24 2015-06-22 Novartis Ag Inhibidores de la nep para el tratamiento de enfermedades caracterizadas por el ensanchamiento o remodelacion auricular.
US20160206597A1 (en) * 2013-08-26 2016-07-21 Toni Lynne Bransford New Use

Also Published As

Publication number Publication date
PT3626270T (pt) 2024-01-11
US20210077461A1 (en) 2021-03-18
HRP20200060T1 (hr) 2020-04-03
EP3626270B1 (en) 2023-10-11
SI3626270T1 (sl) 2024-03-29
EP4321157A3 (en) 2024-05-15
LT3038654T (lt) 2020-01-27
RS65037B1 (sr) 2024-02-29
HRP20240034T1 (hr) 2024-03-29
PL3038654T3 (pl) 2020-05-18
PL3626270T3 (pl) 2024-04-08
HUE047186T2 (hu) 2020-04-28
WO2015028941A1 (en) 2015-03-05
US20160213646A1 (en) 2016-07-28
DK3626270T3 (da) 2024-01-15
HUE064634T2 (hu) 2024-04-28
DK3038654T3 (da) 2020-02-03
EP3038654B1 (en) 2019-10-30
EP4321157A2 (en) 2024-02-14
PT3038654T (pt) 2020-02-04
FI3626270T3 (fi) 2024-01-11
EP3038654A1 (en) 2016-07-06
RS59816B1 (sr) 2020-02-28
EP3626270A1 (en) 2020-03-25
ES2767084T3 (es) 2020-06-16
CY1122531T1 (el) 2021-01-27
JP2016528303A (ja) 2016-09-15
JP6097888B2 (ja) 2017-03-15
LT3626270T (lt) 2024-01-25

Similar Documents

Publication Publication Date Title
PL3038654T3 (pl) Nowe zastosowanie
GB201305825D0 (en) New use
HK1220197A1 (zh) -溴-靛玉紅
HK1204451A1 (en) Novel use
GB201304236D0 (en) Hand-warmer
EP2853297A4 (en) kendama
AU353576S (en) Stamphousing
PL2845826T3 (pl) Wózek przenośnika taśmowego
GB201321223D0 (en) Novel use
GB201321218D0 (en) Novel use
GB201319828D0 (en) Novel use
GB201319824D0 (en) Novel use
GB201318415D0 (en) Novel use
GB201318414D0 (en) Novel use
HU4427U (en) Electrostimulated fitness-machine
GB201322291D0 (en) BangleBand
AU353325S (en) Kettlebell
AU353329S (en) Kettlebell
AU353328S (en) Kettlebell
AU353327S (en) Kettlebell
AU353326S (en) Kettlebell
GB201318606D0 (en) mylCUvoice
AP00812S1 (en) Stumbelbloc
AU2013231V (en) Bonsca7200 Scaevola aemula
GB201313766D0 (en) Attach-A-Bag